An In-home Study of Brain Computer Interfaces
The University of Michigan's study on brain-computer interfaces (BCIs) aims to enhance the independence of individuals with severe paralysis, particularly those with Amyotrophic Lateral Sclerosis (ALS). The market for assistive technologies is growing, driven by an increasing aging population and rising prevalence of neurological disorders. The unique nature of this BCI technology, which allows users to control wheelchairs and communicate, positions it competitively against existing assistive devices. However, the limited enrollment (only one participant) raises concerns regarding scalability and market viability. Further exploration of user experience and technology refinement will be critical for commercial success.
Indication: Amyotrophic Lateral Sclerosis
Modality: medical device
Target: Brain-computer interface (BCI) technology for assistive communication and control of electronic devices.
Sponsor: University of Michigan
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 17, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Brain-computer interface (BCI) technology for assistive communication and control of electronic devices.
View original source fields
Condition raw: Amyotrophic Lateral Sclerosis
Condition normalized: Amyotrophic Lateral Sclerosis
Modality raw: medical device
Modality normalized: medical device
Target raw: Brain-computer interface (BCI) technology for assistive communication and control of electronic devices.
Target normalized: Brain-computer interface (BCI) technology for assistive communication and control of electronic devices.